Senior Director Medical Affairs International

The Group Curium is the world’s largest nuclear medicine company. At Curium, we have a singular focus – to develop, manufacture and supply world‑class radiopharmaceutical products around the globe. With manufacturing facilities across Europe, Middle East and the United States, Curium delivers SPECT, PET and therapeutic radiopharmaceutical solutions for life‑threatening diseases to over 14 million patients annually. Our proven heritage combined with a pioneering approach are the hallmarks to deliver innovation, excellence, and unparalleled service. As a fast‑growing company in a niche market, Curium is today owned by a private equity fund with LBO financing scheme.

Por favor, asegúrese de leer atentamente los siguientes detalles antes de enviar cualquier solicitud.

With over 663 M € revenues in 2024, Curium International is specialized into the production and marketing of 25+ radiopharmaceuticals products, covering 12 indications (such as oncology, cardiology, neuro...